This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/drugbank/drug/DB07876/identifier/pubchem-compound/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07876/identifier/pubchem-substance/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07876/identifier/drugbank/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n6http://linked.opendata.cz/resource/drugbank/drug/DB07876/identifier/chemspider/
n9http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB07876/identifier/pdb/

Statements

Subject Item
n2:DB07876
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n9:DB07876 n13:DB07876
dcterms:title
(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE
adms:identifier
n6:394969 n7:448043 n10:99444347 n11:DB07876 n12:H52
n3:IUPAC-Name
n4:271B47F2-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B47F8-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B47F7-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B47F4-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B47F5-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B47F6-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B47F0-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B47F1-363D-11E5-9242-09173F13E4C5 n4:271B47EE-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B47EF-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B47FE-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B47FF-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B47F9-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B47FA-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B47FC-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B47FB-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B47FD-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4803-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4805-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4806-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4802-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4801-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4804-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B47F3-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4800-363D-11E5-9242-09173F13E4C5